GB201304812D0 - Pro-drug compounds - Google Patents

Pro-drug compounds

Info

Publication number
GB201304812D0
GB201304812D0 GBGB1304812.9A GB201304812A GB201304812D0 GB 201304812 D0 GB201304812 D0 GB 201304812D0 GB 201304812 A GB201304812 A GB 201304812A GB 201304812 D0 GB201304812 D0 GB 201304812D0
Authority
GB
United Kingdom
Prior art keywords
pro
drug compounds
drug
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1304812.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Priority to GBGB1304812.9A priority Critical patent/GB201304812D0/en
Publication of GB201304812D0 publication Critical patent/GB201304812D0/en
Priority to US13/934,665 priority patent/US20140011773A1/en
Priority to US14/410,234 priority patent/US9499510B2/en
Priority to IN10669DEN2014 priority patent/IN2014DN10669A/en
Priority to EP13735378.5A priority patent/EP2870148A1/en
Priority to PCT/GB2013/051767 priority patent/WO2014006407A1/en
Priority to CA2877578A priority patent/CA2877578A1/en
Priority to AU2013285164A priority patent/AU2013285164A1/en
Priority to ZA2014/09213A priority patent/ZA201409213B/en
Ceased legal-status Critical Current

Links

GBGB1304812.9A 2012-07-03 2013-03-15 Pro-drug compounds Ceased GB201304812D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB1304812.9A GB201304812D0 (en) 2013-03-15 2013-03-15 Pro-drug compounds
US13/934,665 US20140011773A1 (en) 2012-07-03 2013-07-03 Pro-drug Compounds
US14/410,234 US9499510B2 (en) 2012-07-03 2013-07-03 Pro-drug compounds
IN10669DEN2014 IN2014DN10669A (en) 2012-07-03 2013-07-03
EP13735378.5A EP2870148A1 (en) 2012-07-03 2013-07-03 Pro-drug compounds
PCT/GB2013/051767 WO2014006407A1 (en) 2012-07-03 2013-07-03 Pro-drug compounds
CA2877578A CA2877578A1 (en) 2012-07-03 2013-07-03 Pro-drug compounds
AU2013285164A AU2013285164A1 (en) 2012-07-03 2013-07-03 Pro-drug compounds
ZA2014/09213A ZA201409213B (en) 2012-07-03 2014-12-15 Pro-drug compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1304812.9A GB201304812D0 (en) 2013-03-15 2013-03-15 Pro-drug compounds

Publications (1)

Publication Number Publication Date
GB201304812D0 true GB201304812D0 (en) 2013-05-01

Family

ID=48226506

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1304812.9A Ceased GB201304812D0 (en) 2012-07-03 2013-03-15 Pro-drug compounds

Country Status (1)

Country Link
GB (1) GB201304812D0 (en)

Similar Documents

Publication Publication Date Title
HRP20171851T1 (en) Tetrahydropyrrolothiazine compounds
GB201309085D0 (en) Compounds
GB201302927D0 (en) Compounds
GB201310542D0 (en) Compounds
GB201311951D0 (en) Compounds
GB201309508D0 (en) Compounds
GB201317619D0 (en) Compounds
ZA201600766B (en) Pro-drug forming compounds
AP3850A (en) Azetidinyloxyphenylpyrrolidine compounds
GB201312901D0 (en) Compounds
ZA201505986B (en) Pro-drug compounds
GB201311953D0 (en) Compounds
GB201322932D0 (en) Pro-drug compounds
EP3010923A4 (en) Pyrroloquinazoline compounds
EP2948457A4 (en) Compounds
GB201306794D0 (en) Compounds
GB201318461D0 (en) Compounds
GB201316014D0 (en) Compounds
GB201310460D0 (en) Compounds
GB201304812D0 (en) Pro-drug compounds
GB201322028D0 (en) Compounds
GB201318323D0 (en) Compounds
GB201318143D0 (en) Compounds
GB201317118D0 (en) Compounds
GB201316717D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)